These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12433039)

  • 1. Radionuclide production for therapeutic radiopharmaceuticals.
    Neves M; Kling A; Lambrecht RM
    Appl Radiat Isot; 2002 Nov; 57(5):657-64. PubMed ID: 12433039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and theoretical study of rhenium radioisotopes production for manufacturing of new compositional radiopharmaceuticals.
    Pourhabib Z; Ranjbar H; Bahrami Samani A; Shokri AA
    Appl Radiat Isot; 2019 Mar; 145():176-179. PubMed ID: 30639634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience on the neutron activation of natural/enriched Re, Sm, and Ho nuclides in a reactor for the production of radiotherapeutic radionuclides.
    Ishfaq MM; Mushtaq A; Jawaid M
    Biol Trace Elem Res; 1999; 71-72():519-26. PubMed ID: 10676528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
    Bardiès M; Chatal JF
    Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles.
    Chattopadhyay S; Vimalnath KV; Saha S; Korde A; Sarma HD; Pal S; Das MK
    Appl Radiat Isot; 2008 Mar; 66(3):334-9. PubMed ID: 17951062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARRONAX project.
    Haddad F; Barbet J; Chatal JF
    Curr Radiopharm; 2011 Jul; 4(3):186-96. PubMed ID: 22201708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of 166Ho through 164Dy(n, gamma)165Dy(n, gamma)166Dy(beta-)166Ho and separation of 166Ho.
    Lahiri S; Volkers KJ; Wierczinski B
    Appl Radiat Isot; 2004 Dec; 61(6):1157-61. PubMed ID: 15388104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy.
    Ferro-Flores G; Hernández-Oviedo O; Arteaga de Murphy C; Tendilla JI; Monroy-Guzmán F; Pedraza-López M; Aldama-Alvarado K
    Appl Radiat Isot; 2004 Dec; 61(6):1227-33. PubMed ID: 15388114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
    Guerra Liberal FD; Tavares AA; Tavares JM
    Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy.
    Ramamoorthy N; Saraswathy P; Das MK; Mehra KS; Ananthakrishnan M
    Nucl Med Commun; 2002 Jan; 23(1):83-9. PubMed ID: 11748442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production logistics of 177Lu for radionuclide therapy.
    Pillai MR; Chakraborty S; Das T; Venkatesh M; Ramamoorthy N
    Appl Radiat Isot; 2003; 59(2-3):109-18. PubMed ID: 12941498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.
    Haddad F; Ferrer L; Guertin A; Carlier T; Michel N; Barbet J; Chatal JF
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1377-87. PubMed ID: 18465127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and purification of Scandium-47: A potential radioisotope for cancer theranostics.
    Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M; Asgari M
    Appl Radiat Isot; 2016 Dec; 118():124-130. PubMed ID: 27640172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of radionuclides in therapy].
    Vucina J; Han R
    Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of 111Ag from neutron irradiated natural palladium using alumina as an adsorbent.
    Khalid M; Mushtaq A; Iqbal MZ
    Appl Radiat Isot; 2000 Jan; 52(1):19-22. PubMed ID: 10670917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A versatile technique for radiochemical separation of medically useful no-carrier-added (nca) radioarsenic from irradiated germanium oxide targets.
    Chattopadhyay S; Pal S; Vimalnath KV; Das MK
    Appl Radiat Isot; 2007 Nov; 65(11):1202-7. PubMed ID: 17656098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment.
    Torres M; Ayra E; Albuerne O; Montano Delgado MA
    Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of beta-absorbed fractions in a mouse model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionuclides.
    Miller WH; Hartmann-Siantar C; Fisher D; Descalle MA; Daly T; Lehmann J; Lewis MR; Hoffman T; Smith J; Situ PD; Volkert WA
    Cancer Biother Radiopharm; 2005 Aug; 20(4):436-49. PubMed ID: 16114992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.